WeChat Mini Program
Old Version Features
Research Interests

Papers共 11 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Discovery of HMPL-306 (ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment
Kun Xiao, Zheng Zhang, Yao Wu, Gang Li, Jia Chen,Yongxin Ren,Na Yang, Jinghong Zhou, Wei Zhang,Jian Wang,Zeyu Zhong, Sumei Xia, Guanglin Wang, Na Li, Wenji Li, Ling Feng,Weihan Zhang,Weiguo Su,Guangxiu Dai
ACS medicinal chemistry lettersno. 3 (2025): 454-463
Cited0Views0WOSBibtex
0
0
HMPL-653, a Highly Potent and Selective CSF-1R Inhibitor, Targeting Both Tumor Cells and Tumor Microenvironment
Jia Hu, Liang Ge,Hui Zhang, An Jiang, Juntao Yu, Weifang Xue,Jian Wang, Yang Sai,Na Yang, Weiguo Qing, Yongxin Ren,Michael Shi,Weiguo Su
MOLECULAR CANCER THERAPEUTICSno. 12 (2023)
Cited0Views0Bibtex
0
0
Preclinical Characterization of HMPL-415, a Second-Generation SHP2 Inhibitor
Jia Hu,Jun Ni, Zhihu Gao,Xiaoqing Liu, Hui Zhang,Pan Wang,Min Cheng,Guanglin Wang, Zeyu Zhong,Jian Wang, Yang Sai,Na Yang, Weiguo Qing, Yongxin Ren,Michael Shi,Weiguo Su
MOLECULAR CANCER THERAPEUTICSno. 12 (2023)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 11

#Citation: 12

H-Index: 2

G-Index: 3

Sociability: 4

Diversity: 1

Activity: 7

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn